BioRegenx, Inc
BioRegenx Inc., headquartered in Chattanooga, TN, is at the forefront of health intelligence, leveraging patented technologies and artificial intelligence to advance regenerative biotherapeutics and wellness solutions. The company focuses on developing non-invasive medical devices aimed at efficiently recording and analyzing extensive health data, including innovations for monitoring the endothelial glycocalyx and microvascular system.
The company boasts a portfolio of three patented technologies: GlycoCheck, Endocalyx Pro, and DocSun, each designed to enhance microvascular health and enable contactless vital health monitoring. Through a strategic direct-to-institution, direct-to-practitioner, and direct-to-consumer sales model, BioRegenx aims to capture significant market share in the global health and wellness landscape.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.